Biggest News Aggregation in the World
📰 Efficient Ascas News

Efficient Ascas News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Efficient Ascas. Real-time updates on events, politics, business and more.

Editas Medicine Announces Positive Initial EDIT-301 Safety and Efficacy Data from the First Four Patients Treated in the RUBY Trial and the First Patient Treated in the EdiTHAL Trial

EDIT-301 was well-tolerated and demonstrated a safety profile consistent with myeloablative conditioning with busulfan and autologous hematopoietic stem cell transplant First two RUBY patients... | June 9, 2023
United Kingdom United States Rabi Hanna Baisong Mei European Hematology Association Editas Medicine Inc

Editas Medicine to Present Clinical Data from the RUBY Trial of EDIT-301 for the Treatment of Severe Sickle Cell Disease at the EHA 2023 Congress

Company-sponsored webinar to be announcedCAMBRIDGE, Mass., May 11, 2023 -- Editas Medicine, Inc. , a clinical stage genome editing company, today announced that a scientific abstract detailing... | May 11, 2023
United States United Kingdom Baisong Mei Rabi Hanna Harvard University Cas Department Of Pediatric Hematology Oncology

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science